|
Name |
Penexanthone B
|
Molecular Formula | C19H20O8 | |
IUPAC Name* |
[(3R,4R,4aR)-4-acetyloxy-8,9-dihydroxy-3-methyl-1-oxo-3,4-dihydro-2H-xanthen-4a-yl]methyl acetate
|
|
SMILES |
C[C@@H]1CC(=O)C2=C(C3=C(C=CC=C3O[C@@]2([C@@H]1OC(=O)C)COC(=O)C)O)O
|
|
InChI |
InChI=1S/C19H20O8/c1-9-7-13(23)16-17(24)15-12(22)5-4-6-14(15)27-19(16,8-25-10(2)20)18(9)26-11(3)21/h4-6,9,18,22,24H,7-8H2,1-3H3/t9-,18-,19+/m1/s1
|
|
InChIKey |
NHGCHJUCHVUXHO-VUXJGSIMSA-N
|
|
Synonyms |
Penexanthone B; Rel-Penexanthone B; CHEMBL2036660; (3R)-1,8-Dihydroxy-3beta-methyl-4beta-acetoxy-4aalpha-(acetoxymethyl)-2,3,4,4a-tetrahydro-9H-xanthene-9-one
|
|
CAS | NA | |
PubChem CID | 57409768 | |
ChEMBL ID | CHEMBL2036660 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 376.4 | ALogp: | 1.5 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 119.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 27 | QED Weighted: | 0.773 |
Caco-2 Permeability: | -5.088 | MDCK Permeability: | 0.00003610 |
Pgp-inhibitor: | 0.033 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.066 | 20% Bioavailability (F20%): | 0.246 |
30% Bioavailability (F30%): | 0.737 |
Blood-Brain-Barrier Penetration (BBB): | 0.668 | Plasma Protein Binding (PPB): | 58.64% |
Volume Distribution (VD): | 0.588 | Fu: | 49.89% |
CYP1A2-inhibitor: | 0.215 | CYP1A2-substrate: | 0.083 |
CYP2C19-inhibitor: | 0.172 | CYP2C19-substrate: | 0.121 |
CYP2C9-inhibitor: | 0.307 | CYP2C9-substrate: | 0.369 |
CYP2D6-inhibitor: | 0.35 | CYP2D6-substrate: | 0.122 |
CYP3A4-inhibitor: | 0.747 | CYP3A4-substrate: | 0.302 |
Clearance (CL): | 2.913 | Half-life (T1/2): | 0.702 |
hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.94 |
Drug-inuced Liver Injury (DILI): | 0.933 | AMES Toxicity: | 0.077 |
Rat Oral Acute Toxicity: | 0.694 | Maximum Recommended Daily Dose: | 0.034 |
Skin Sensitization: | 0.102 | Carcinogencity: | 0.087 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.045 |
Respiratory Toxicity: | 0.225 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005071 | 0.516 | D08NQZ | 0.287 | ||||
ENC003646 | 0.478 | D0S0LZ | 0.287 | ||||
ENC002870 | 0.476 | D0T6WT | 0.274 | ||||
ENC001973 | 0.455 | D0J2NK | 0.272 | ||||
ENC001969 | 0.450 | D0N1FS | 0.270 | ||||
ENC002978 | 0.445 | D0H1AR | 0.266 | ||||
ENC004047 | 0.443 | D0OL7F | 0.265 | ||||
ENC002105 | 0.431 | D05AFR | 0.257 | ||||
ENC001968 | 0.422 | D01XWG | 0.257 | ||||
ENC001991 | 0.420 | D04VEJ | 0.253 |